Ubs Asset Management Americas Inc Neurocrine Biosciences Inc Transaction History
Ubs Asset Management Americas Inc
- $381 Billion
- Q3 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 894,217 shares of NBIX stock, worth $110 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
894,217
Previous 912,064
1.96%
Holding current value
$110 Million
Previous $126 Million
18.01%
% of portfolio
0.03%
Previous 0.04%
Shares
28 transactions
Others Institutions Holding NBIX
# of Institutions
624Shares Held
94.2MCall Options Held
632KPut Options Held
621K-
Black Rock Inc. New York, NY14.2MShares$1.75 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$1.23 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.15MShares$635 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.57MShares$317 Million0.47% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.86MShares$230 Million3.62% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.8B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...